Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative efficacy and acceptability of drug treatments for Parkinson’s disease with depression: A systematic review with network meta-analysis
Xiaole Wang, Sitong Feng, Yating Wang, et al.
European Journal of Pharmacology (2022) Vol. 927, pp. 175070-175070
Closed Access | Times Cited: 17

Showing 17 citing articles:

Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives
Elisa Mantovani, Chiara Zucchella, Andreas A. Argyriou, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 1, pp. 25-43
Closed Access | Times Cited: 19
Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases
Ole Köhler‐Forsberg, Victoria Stiglbauer, Jelena Brasanac, et al.
JAMA Psychiatry (2023) Vol. 80, Iss. 12, pp. 1196-1196
Open Access | Times Cited: 16
Parkin, a Parkinson's disease-associated protein, mediates the mitophagy that plays a vital role in the pathophysiology of major depressive disorder
Yi Zhang
Neurochemistry International (2024) Vol. 179, pp. 105808-105808
Closed Access | Times Cited: 7
Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
Efthalia Angelopoulou, Evangelia Stanitsa, Claire Chrysanthi Karpodini, et al.
Medicina (2023) Vol. 59, Iss. 8, pp. 1454-1454
Open Access | Times Cited: 14
Efficacy of ginsenoside Rg1 on rodent models of depression: A systematic review and meta-analysis
Yating Wang, Xiaole Wang, Lei Lan, et al.
Psychopharmacology (2024)
Closed Access | Times Cited: 5
Berberine: an isoquinoline alkaloid targeting the oxidative stress and gut-brain axis in the models of depression
Cong-Ya Chen, Yi Zhang
European Journal of Medicinal Chemistry (2025), pp. 117475-117475
Closed Access
Treatment options for depression in Parkinson’s disease: a mini-review
Alberto Raggi, Alessandro Serretti, Raffaele Ferri
International Clinical Psychopharmacology (2025)
Closed Access
Drug Treatment of Psychiatric Symptoms Occurring in the Context of Other Conditions

(2025), pp. 803-864
Closed Access
MicroRNA-specific targets for neuronal plasticity, neurotransmitters, neurotrophic factors, and gut microbes in the pathogenesis and therapeutics of depression
Cong-Ya Chen, Yufei Wang, Lan Lei, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111186-111186
Closed Access | Times Cited: 3
Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Renjie Gao, Panpan Zhao, Kai Yan
Clinical Drug Investigation (2024) Vol. 44, Iss. 7, pp. 459-469
Closed Access | Times Cited: 2
Efficacy of Chinese herbal formula Kai-Xin-San on rodent models of depression: A systematic review and meta-analysis
Yating Wang, Xiaole Wang, Lei Lan, et al.
Journal of Ethnopharmacology (2023) Vol. 321, pp. 117492-117492
Closed Access | Times Cited: 5
Locus coeruleus injury modulates ventral midbrain neuroinflammation during DSS-induced colitis
Jake Boles, Jenny Holt, Cassandra L. Cole, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Locus coeruleus injury modulates ventral midbrain neuroinflammation during DSS-induced colitis
Malú G. Tansey, Jake Boles, Jenny Holt, et al.
Research Square (Research Square) (2024)
Open Access
Efficacy and safety of classical herbal formula Xiao-Yao-San in depression: A systematic review and meta-analysis
Y Wang, Xiaole Wang, Yi Zhang
Research Square (Research Square) (2024)
Closed Access
Serum neurotransmitter analysis of motor and non-motor symptoms in Parkinson’s patients
Yichun Fan, Wenping Yang, Weilan Wu, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Parkinson's Disease: A Systematic Review and Meta-Analysis Running head: Meta-Analysis of Parkinson's Disease
Renjie Gao, Panpan Zhao, Kai Yan
Research Square (Research Square) (2023)
Closed Access
Cerebrospinal fluid biomarkers for the subtle differentiation of neurodegenerative diseases and psychiatric disorders: A systematic review with network meta-analysis
Yating Wang, Sitong Feng, Bin Chen, et al.
Research Square (Research Square) (2023)
Open Access
Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson’s Disease
Daniel J. van Wamelen, Valentina Leta, К. Ray Chaudhuri, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 10, pp. 1606-1620
Closed Access
Page 1

Scroll to top